{"disease":{"id":"blepharitis","name":"blepharitis"},"drugs":{"marketed":[{"drug_id":"azithromycin","indication_name":"Bacterial blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zithromax","generic_name":"azithromycin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Canalicular multispecific organic anion transporter 1, Taste receptor type 2 member 4, Motilin receptor","drug_class":"Macrolide antibiotic (azalide)","quality_score":67,"revenue":"399","mechanism":"Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life."},{"drug_id":"bacitracin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"BACITRACIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase Lck","drug_class":"bacitracin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"gentamicin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Garamycin","generic_name":"GENTAMICIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 5","drug_class":"Aminoglycoside Antibacterial","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"tobramycin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tobi","generic_name":"tobramycin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone-acetate","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"sulfacetamide","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klaron","generic_name":"SULFACETAMIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Sulfonamide Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"natacyn","indication_name":"Fungal Blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NATACYN®","company_name":"IVIEW Therapeutics Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"lotilaner","indication_name":"Demodex blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xdemvy","generic_name":"LOTILANER","company_name":"Tarsus","drug_phase":"marketed","molecular_target":"","drug_class":"Ectoparasiticide [EPC]","quality_score":41,"revenue":null,"mechanism":"Xdemvy works by targeting and killing Demodex mites that cause blepharitis."},{"drug_id":"tobramycin-sulfate","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vantobra","generic_name":"Tobramycin Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20","drug_class":"tobramycin","quality_score":68,"revenue":null,"mechanism":""},{"drug_id":"gentamicin-sulfate","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gentamicin","generic_name":"Gentamicin Sulfate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"gentamicin","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"nebcin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Nebcin","company_name":"University Hospital, Lille","drug_phase":"discontinued","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"neomycin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"NEOMYCIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 1","drug_class":"Aminoglycoside Antibacterial","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"natamycin","indication_name":"Fungal Blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Natacyn","generic_name":"NATAMYCIN","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"","drug_class":"Polyene Antimicrobial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"polymyxin-b","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"POLYMYXIN B","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Polymyxin-class Antibacterial","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"gramicidin","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gramoderm","generic_name":"GRAMICIDIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"gramicidin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fusidic-acid","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"prednisolon","indication_name":"Infective blepharitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":22,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03652415","title":"DRy Eye Outcome and Prescription Study","phase":"","overall_status":"UNKNOWN","enrollment_count":635,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT00008541","title":"Evaluation and Treatment of Patients With Corneal and External Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT01543490","title":"Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"Sun Pharmaceutical Industries Limited","has_results":true},{"nct_id":"NCT06400511","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":477,"lead_sponsor_name":"Famy Life Sciences, a Viatris Company","has_results":false},{"nct_id":"NCT04475432","title":"Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":421,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04784091","title":"Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":412,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04675242","title":"Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Nicox Ophthalmics, Inc.","has_results":true},{"nct_id":"NCT06235450","title":"A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Olympic Ophthalmics, Inc.","has_results":false},{"nct_id":"NCT05629390","title":"Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"LianBio LLC","has_results":false},{"nct_id":"NCT06182358","title":"Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT01115192","title":"Blephacura Versus Baby Shampoo to Treat Blepharitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT04469998","title":"Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"AxeroVision, Inc.","has_results":true},{"nct_id":"NCT04377841","title":"Facial Demodicosis and Ocular Demodicosis","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT02386774","title":"Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT07451678","title":"Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Instituto de Oftalmología Fundación Conde de Valenciana","has_results":false},{"nct_id":"NCT05608980","title":"0.01% Hypochlorous Acid in the Treatment of Blepharitis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT07169461","title":"Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blepharitis Using Artificial Intelligent Program (Ai-Demodex)","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":88,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT06520007","title":"Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT04603222","title":"Evaluation of SUMMIT BRUSH in Treatment of Blepharitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Notre Dame","has_results":false},{"nct_id":"NCT04858113","title":"Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"University of Plymouth","has_results":false},{"nct_id":"NCT05139511","title":"Analysis of the Results of Intense Pulsed Light Treatment Previously to Laser Refractive Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Vissum, Instituto Oftalmológico de Alicante","has_results":false},{"nct_id":"NCT04780165","title":"Efficacy and Tolerability of Blephademodex Wipes","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Laboratoires Thea","has_results":false},{"nct_id":"NCT04678531","title":"TTO Swabs Versus Baby Shampoo in Patients With Seborrehic Blepharitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT04441528","title":"Lid Wipes Versus Baby Shampoo in Patients With Seborrehic Blepharitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT05062564","title":"Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","has_results":false},{"nct_id":"NCT04742855","title":"Probiotics for Blepharitis in Adults and Children","phase":"","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"University of Molise","has_results":false},{"nct_id":"NCT05454956","title":"Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06371300","title":"Photobiomodulation With REd vs BluE Light (REBEL)","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Aston University","has_results":false},{"nct_id":"NCT03926026","title":"Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Nicox Ophthalmics, Inc.","has_results":true},{"nct_id":"NCT06054217","title":"Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tarsus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06795165","title":"Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Eye Research Foundation, Inc.","has_results":false},{"nct_id":"NCT03301844","title":"To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"NTC srl","has_results":true},{"nct_id":"NCT03302273","title":"Corneal Epithelial Stem Cells and Dry Eye Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Sloan W. Rush, MD","has_results":false},{"nct_id":"NCT04290455","title":"Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"University of California, Los Angeles","has_results":false}],"total":34},"guidelines":[],"source":"Drug Landscape verified database"}